by U.S. DHEW, PHS, Food and Drug Administration, Bureau of Radiological Health, Division of Biological Effects, Experimental Studies Branch in Rockville, MD .
Written in English
Bibliography: p. 13-21.
|Statement||Larry E. Bockstahler, C. David Lytle, Kiki B. Hellman.|
|Series||DHEW publication -- no. (FDA) 75-8013, DHEW publication -- no. (FDA) 75-8013, DHEW publication -- no. (FDA) 75-8013|
|Contributions||Bockstahler, Larry E., Lytle, C. David., Hellman, Kiki B., United States. Bureau of Radiological Health. Division of Biological Effects.|
|The Physical Object|
|Pagination||viii, 21 p. ;|
|Number of Pages||21|
Get this from a library! A review of photodynamic therapy for herpes simplex: benefits and potential risks. [Larry B Bockstahler; Kiki B Hellman; C David Lytle; United States. Bureau of Radiological Health. Division of Biological Effects. Experimental Studies Branch.]. Consult with a doctor virtually or in person BOOK A CONSULTATION. HOME / REVIEWS / PHOTODYNAMIC THERAPY REVIEWS; Photodynamic Therapy Reviews. RealSelf features Photodynamic Therapy reviews you can trust, from real people like you. More about Photodynamic Therapy. 85 % WORTH IT. Based on 2 recent ratings. Material and methods: In an initial study, patients with herpes simplex type 1 virus symptoms were consecutively selected for either LLLT or conventional therapy, including acyclovir cream or. The present systematic review was designed to address the research question: “Is photodynamic therapy effective in the treatment and prevention of recurrent herpes labialis?”. Surprisingly, no randomized control trials or controlled clinical trials Cited by: 4.
We want to propose a pilot study with 10 patients for the treatment of Herpes simplex infection with photodynamic therapy effected by a nm diode lamp and associated photosensitizer. View Show. We report the case of an 81‐year‐old male patient who developed a reactivation of herpes simplex virus localized to the right forehead, where photodynamic therapy (PDT) for actinic keratosis was performed. Herpes is a viral disease, caused by herpes simplex virus type 1 (HSV‐1) and type 2 (HSV‐2). HSV enters the host through skin and mucosal surfaces, commonly the oral cavity, genital tract, and cornea of the eye, by means of direct contact with infected secretions. H erpes simplex virus (HSV) is a major health concern. This is evidenced by the epidemic of genital herpes and the enhanced acquisition of human immunodeficiency virus (HIV) associated with HSV. 1 Its prevalence in the ocular world is just as strong, with HSV keratitis (HSVK) standing as the leading infectious cause of corneal blindness among developed nations, primarily because of its.
simplex virus-l, herpes simplex virus-2 and varicella zoster virus in the search for the most potent sensitizers for viral decontamination of blood. min after the onset of adsorption, are highly resistant to photodynamic treatment by most photosensitizers, with the . Therapy consisted of rupturing early vesicular lesions, application of the dye, and subsequent exposure to fluorescent light for 15 minutes. Eighteen of 20 patients treated with the active medication noted symptomatic improvement superior to that experienced with any form of therapy previously used. Background Data and Objective: Herpes is a common infectious disease that is caused by human herpesviruses. Several treatments have been proposed, but none of them prevent reactivation of the virus. This article describes the use of photodynamic therapy (PDT) as a treatment for herpes lesions, and reports on four cases. Marotti J, Aranha AC, Eduardo Cde P, Ribeiro MS. Photodynamic therapy can be effective as a treatment for herpes simplex labialis. Photomed Laser Surg. Apr;27(2) doi: /pho